Multiple-Breath Washout Outcomes Are Sensitive to Inflammation and Infection in Children with Cystic Fibrosis
Kathryn A Ramsey, Rachel E Foong, Jasmine Grdosic, Alana Harper, Billy Skoric, Charles Clem, Miriam Davis, Lidija Turkovic, Stephen M Stick, Stephanie D Davis, Sarath C Ranganathan, Graham L Hall
Annals of the American Thoracic Society | AMER THORACIC SOC | Published : 2017
Awarded by Cystic Fibrosis Foundation Therapeutics
Awarded by National Health and Medical Research Council of Australia (NHMRC)
Awarded by NHMRC
Funding for the Australian Respiratory Early Surveillance Team for Cystic Fibrosis program was obtained from the Cystic Fibrosis Foundation Therapeutics (SLY04A0, STICK09A0, and HALL14A0), the National Health and Medical Research Council of Australia (NHMRC; APP513730, APP1020555, and Centre of Research Excellence 1000896), and the Institute for Respiratory Health (2012 [K.A.R.]), and NHMRC fellowships APP1088389 (K.A.R) and APP125550 (G.L.H.). Additional funding was obtained from the Cystic Fibrosis Foundation Therapeutics (DAVIS08Y2 [S.D.D., C.C.]).